Tuesday, October 20th, 2009
Forest Laboratories, Inc. (NYSE: FRX) and Cypress Bioscience, Inc.
Wednesday, June 10th, 2009
As many as fifteen million American women suffer from a disabling medical condition known as fibromyalgia. In the medical community, sides have been drawn over whether fibromyalgia is a genuine syndrome or a catchall diagnosis based on vague clinical criteria. In The Fibromyalgia Controversy, M. Clement Hall, MD presents an unbiased overview of the fibromyalgia situation today and reviews the most up-to-date opinions and studies on this condition and its surrounding controversy.